Retracted article: The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Objective This study was conducted to evaluate the effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of women with polycystic ovary syndrome (PCOS).Methods This randomized double-blind, placebo-controlled trial was conducted on 60 women with PCOS, aged 18–40 years old. Participants were randomly assigned into two groups to receive either 2 × 1000 mg/day fish oil omega-3 fatty acid (n = 30) or placebo (n = 30) after lunch for 12 weeks. Metabolic profiles were quantified at baseline and after the 12-week intervention.Results Compared with the placebo, omega-3 fatty acid intake led to a significant improvement in Beck Depression Inventory [β (difference in the mean outcomes measures between treatment groups after intervention) –1.05; 95% CI: –1.84, –0.26; p = .01], general health questionnaire (β –1.68; 95% CI: –3.12, –0.24; p = .02) and depression anxiety and stress scale (β –2.03; 95% CI: –3.60, –0.46; p = .01). Omega-3 fatty acid supplementation significantly decreased serum insulin levels (β –2.09 µIU/mL; 95% CI: –3.77, –0.41; p = .01), homeostasis model of assessment-insulin resistance (β –0.74; 95% CI: –1.13, –0.34; p < .001), total testosterone (β –0.23 ng/mL; 95% CI: –0.39, –0.06; p = .03) and hirsutism (β –0.75; 95% CI: –1.17, –0.33; p = .001), and significantly increased the quantitative insulin sensitivity check index (β 0.01; 95% CI: 0.003, 0.02; p = .008) compared with the placebo. Additionally, omega-3 fatty acid intake resulted in a significant decrease in high sensitivity C-reactive protein (β –1.46 mg/L; 95% CI: –2.16, –0.75; p < .001) and malondialdehyde (β –0.28 µmol/L; 95% CI: –0.52, –0.05; p = .03); also significant rises in plasma total glutathione (β 59.09 µmol/L; 95% CI: 7.07, 111.11; p = .02) was observed compared with the placebo. Omega-3 fatty acid supplementation did not change other metabolic parameters.Conclusion Overall, omega-3 fatty acid supplementation for 12 weeks to patients with PCOS had beneficial effects on mental health parameters, insulin metabolism, total testosterone, hirsutism and few inflammatory markers and oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crawford, J. R., & Henry, J. D. (2004) · British Journal of Clinical Psychology · doi:10.1348/0144665031752934 · Cited by 2,957 · cited 1×
“DASS questionnaire consists of three 14-item self-report scales that measure depression, anxiety and stress [27].”
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome
Legro, R. S., Kunselman, A. R., & Dunaif, A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00948-2 · Cited by 622
Lin, P.-Y., & Su, K.-P. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0712 · Cited by 481
Lipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.027 · Cited by 477
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466 · cited 1×
“factor associated with the typical clinical signs and hormonal disorders in patients with PCOS, and this trait has cause-consequence relationships with increased risk of CVD [47] and T2DM [48].”
Essential Fatty Acids and the Brain
Haag, M. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800308 · Cited by 421
Appleton, K. M., Rogers, P. J., & Ness, A. R. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28313 · Cited by 353
Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis
Barry, J. A., Kuczmierczyk, A. R., & Hardiman, P. J. (2011) · Human Reproduction · doi:10.1093/humrep/der197 · Cited by 336
Is PCOS an inflammatory process?
Duleba, A. J., & Dokras, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.023 · Cited by 327 · cited 1×
“In patients with PCOS, it was reported that pro-inflammatory parameters and oxidative stress increase [57].”
Cited by
Tosatti, J. A. G., Alves, M. T., Cândido, A. L., Reis, F. M., Araújo, V. E., & Gomes, K. B. (2021) · British Journal of Nutrition · doi:10.1017/s0007114520003207 · Cited by 38
Xia, Y., Wang, Y., Cui, M., & Su, D. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1050 · Cited by 23
Yuan, J., Wen, X., & Jia, M. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-2018 · Cited by 22
“Finally, 10 studies (21-30) were enrolled in our meta-analysis.”
BackgroundZhou, J., Zuo, W., Tan, Y., Wang, X., Zhu, M., & Zhang, H. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01130-4 · Cited by 16
Metadata
- Authors
- Amini, M., Bahmani, F., Foroozanfard, F., Vahedpoor, Z., Ghaderi, A., Taghizadeh, M., Karbassizadeh, H., & Asemi, Z.
- Venue
- Journal of Psychosomatic Obstetrics & Gynecology
- Publisher
- Informa UK Limited
- Published
- 2018-09-19
- Volume
- 45
- Issue
- 1
- Pages
- 1508282-1508282
- ISSN
- 0167-482X (ISSN-L)
- 1743-8942
- OpenAlex
- W2891933883
- Cited by
- 31
- References
- 15
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retracted article: The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1080/0167482x.2018.1508282
- The paper
- Amini, M., Bahmani, F., Foroozanfard, F., Vahedpoor, Z., Ghaderi, A., Taghizadeh, M., Karbassizadeh, H., & Asemi, Z. (2024). Retracted article: The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Journal of Psychosomatic Obstetrics & Gynecology. https://doi.org/10.1080/0167482x.2018.1508282
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.